Browse > Article
http://dx.doi.org/10.3746/jkfn.2011.40.3.385

Co-Culture Model Using THP-1 Cell and HUVEC on AGEs-Induced Expression of Cytokines and RAGE  

Lee, Kwang-Won (Division of Food Bioscience & Technology, College of Life Science and Biotechnology, Korea University)
Lee, Hyun-Sun (Dept. Food and Nutrition and Institute of Health Science, Korea University)
Publication Information
Journal of the Korean Society of Food Science and Nutrition / v.40, no.3, 2011 , pp. 385-392 More about this Journal
Abstract
Although monoculture methods have been remarkably useful due to their simplicity, they have serious limitation because of the different types of cells communication with each other in many physiological situations. We demonstrated levels of markers of endothelial dysfunction such as tumor necrosis factor-$\alpha$ (TNF-$\alpha$) and interleukin-1$\beta$ (IL-1$\beta$) as well as stimulation of receptor of advanced glycation endproducts (AGEs) on monoand co-culture system such as only monocyte (THP-1) cultivation system, only endothelial cell (HUVEC) cultivation system, and co-cultivation system of THP-1 and HUVEC. The mRNA levels of TNF-$\alpha$ and IL-1$\beta$ on HUVEC increased by the co-culture with monocyte after 4 hr at 100 ${\mu}g/mL$ glyceraldehyde-AGE. The secreted protein contents into medium of TNF-$\alpha$ and IL-1$\beta$ increased after 8 hr approximately 2~2.5 times compared to mono-cultivation. In contrast, the mRNA level of receptor of AGE (RAGE) was relatively insensitive on the co-culture system. The mediators by which monocytes activate endothelial cell have not been fully elucidated. In this study we confirmed production of soluble cytokines such as TNF-$\alpha$ and IL-1$\beta$ by monocytes. Use of monocyte conditioned medium, which contains both cytokines, can activate endothelial cell.
Keywords
advanced glycation endproducts (AGEs); endothelial dysfunction; co-culture; endothelial cell; monocyte;
Citations & Related Records

Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 Munch G, Schinzel R, Loske C, Wong A, Durany N, Li JJ,Vlassara H, Smith MA, Perry G, Riederer P. 1998.Alzheimer's disease-synergistic effects of glucose deficit,oxidative stress and advanced glycation endproducts. J Neural Transm 105 : 439-461.   DOI
2 Matsuse T, Ohga E, Teramoto S, Fukayama M, Nagai R,Horiuchi S, Ouchi Y. 1988. Immunohistochemical localisation of advanced glycation end products in pulmonary fibrosis. J Clin Pathol 51: 515-519.
3 Dunon D, Piali L, Imhof B. 1996. To stick or not to stick-the new leukocyte homing paradigm. Curr Opin Cell Biol 8:714-723.   DOI
4 Niiya Y, Abumiya T, Shichinohe H, Kuroda S, Kikuchi S,Ieko M, Yamagishi S, Takeuchi M, Sato T, Iwasaki Y. 2006.Susceptibility of brain microvascular endothelial cells to advanced glycation end products-induced tissue factor upregulation is associated with intracellular reactive oxygen species. Brain Res 1108: 179-187.   DOI
5 Tsouknos A, Nash GB, Rainger GE. 2003. Monocytes initiate a cycle of leukocyte recruitment when cocultured with endothelial cells. Atherosclerosis 170: 49-58.   DOI
6 Lee SJ, Lee WK. 2007. Protective effect of (-)-epigallocatechin gallate against advanced glycation endproducts-induced injury in neuronal cells. Biol Pharm Bull 30: 1369-1373.   DOI
7 Shibata M, Hariya T, Hatao M, Ashikaga T, Ichikawa P. 1999. Quantitative polymerase chain reaction using an external control mRNA for determination of gene expression in a heterogeneous cell population. Toxicol Sci 49: 290-296.   DOI   ScienceOn
8 Tanji K, Mori F, Imaizumi T, Yoshida H, Matsumiya T,Tamo W, Yoshimoto M, Odagiri H, Sasaki M, TakahashiH, Satoh K, Wakabayashi K. 2002. Upregulation of $\alpha$-synuclein by lipopolysaccharide and interleukin-1 in human macrophages. Pathology International 52: 572-577.   DOI
9 Heraud JM, Lavergne A, Kazanji M. 2002. Molecular cloning, characterization, and quantification of squirrel monkey (Saimiri sciureus) Th1 and Th2 cytokines. Immunogenetics 54: 20-29.   DOI
10 Khalifah RG, Baynes JW, Hudson BG. 1999. Amadorins: novel post-Amadori inhibitors of advanced glycation reactions. Biochem Biophys Res Commun 257: 251-258.   DOI
11 Sato T, Shimogaito N, Wu X, Kikuchi S, Yamagishi S,Takeuchi M. 2006. Toxic advanced glycation end products (TAGE) theory in Alzheimer's disease. Am J Alzheimers Dis Other Demen 21: 197-208.   DOI
12 Takada M, Ku Y, Toyama H, Suzuki Y, Kuroda Y. 2002.Suppressive effects of tea polyphenol and conformational changes with receptor for advanced glycation end products (RAGE) expression in human hepatoma cells. Hepatogastroenterology49: 928-931.
13 Ahmad MS, Ahmed N. 2006. Antiglycation properties of aged garlic extract: possible role in prevention of diabetic complications. J Nutr 136: 796S-799S.   DOI
14 Basta G, Schmidt AM, De Caterina R. 2004. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res63: 582-592.   DOI
15 Lee HS, Koo YC, Suh HJ, Kim KY, Lee KW. 2010.Preventive effects of chebulic acid isolated from Terminalia chebula on advanced glycation endproduct-induced endothelial cell dysfunction. J Ethnopharmacol 131: 567-574.   DOI   ScienceOn
16 Speciale A, Canali R, Chirafisi J, Saija A, Virgili F, Cimino F. 2010. Cyanidin-3-O-glucoside protection against TNF-alpha-induced endothelial dysfunction: involvement of nuclear factor-kappaB signaling. J Agric Food Chem 58:12048-12054.   DOI   ScienceOn
17 Devaraj S, Dasu MR, Rockwood J, Winter W, Griffen SC,Jialal I. 2008. Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state. J Clin Endocrinol Metab 93: 578-583.   DOI
18 Takeuchi M, Makita Z, Bucala R, Suzuki T, Koike T,Kameda Y. 2000. Immunological evidence that non-carbox-ymethyllysineadvanced glycation end-products are produced from short chain sugars and dicarbonyl compounds in vivo. Mol Med 6: 114-125.
19 Okamoto T, Yamagishi S, Inagaki Y, Amano S, TakeuchiM, Kikuchi S, Ohno S, Yoshimura A. 2002. Incadronate disodium inhibits advanced glycation end products-induced angiogenesis in vitro. Biochem Biophys Res Commun 297:419-424.   DOI
20 Hsieh CL, Lin YC, Ko WS, Peng CH, Huang CN, Peng RY.2005. Inhibitory effect of some selected nutraceutic herbs on LDL glycation induced by glucose and glyoxal. J Ethnopharmacol 102: 357-363.   DOI
21 Ma H, Li SY, Xu P, Babcock SA, Dolence EK, BrownleeM, Li J, Ren J. 2009. Advanced glycation endproduct (AGE) accumulation and AGE receptor (RAGE) upregulation contribute to the onset of diabetic cardiomyopathy. J Cell Mol Med 13: 1751-1764.   DOI
22 Lue LF, Walker DG, Brachova L, Beach TG, Rogers J,Schmidt AM, Stern DM, Yan SD. 2001. Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism. Exp Neurol 171: 29-45.   DOI
23 Sobenin IA, Tertov VV, Koschinsky T, Bunting CE,Slavina ES, Dedov II, Orekhov AN. 1993. Modified low density lipoprotein from diabetic patients causes cholesterol accumulation in human intimal aortic cells. Atherosclerosis100: 41-54.   DOI
24 Magalhaes PM, Appell HJ, Duarte JA. 2008. Involvement of advanced glycation end products in the pathogenesis of diabetic complications: the protective role of regular physical activity. Eur Rev Aging Phys A 5: 17-29.   DOI
25 Goh SY, Cooper ME. 2008. Clinical review: The role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab 93: 1143-1152.   DOI
26 Linden E, Cai W, He JC, Xue C, Li Z, Winston J, VlassaraH, Uribarri J. 2008. Endothelial dysfunction in patients with chronic kidney disease results from advanced glycation end products (AGE)-mediated inhibition of endothelial nitric oxide synthase through RAGE activation. Clin J Am Soc Nephrol 3: 691-698.   DOI
27 Lo CY, Li S, Tan D, Pan MH, Sang S, Ho CT. 2006.Trapping reactions of reactive carbonyl species with tea polyphenols in simulated physiological conditions. Mol Nutr Food Res 50: 1118-1128.   DOI
28 Mullarkey CJ, Edelstein D, Brownlee M. 1990. Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem Biophys Res Commun 173: 932-939.   DOI
29 Monnier VM, Elmets CA, Frank KE, Vishwanath V, YamashitaT. 1986. Age-related normalization of the browning rate of collagen in diabetic subjects without retinopathy.J Clin Invest 78: 832-835.   DOI
30 Vishwanath V, Frank KE, Elmets CA, Dauchot PJ, MonnierVM. 1986. Glycation of skin collagen in type I diabetes mellitus. Correlation with long-term complications. Diabetes35: 916-921.   DOI
31 Makita Z, Bucala R, Rayfield EJ, Friedman EA, KaufmanAM, Korbet SM, Barth RH, Winston JA, Fuh H, ManogueKR. 1994. Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure. Lancet 343: 1519-1522.   DOI
32 Hammes HP, Alt A, Niwa T, Clausen JT, Bretzel RG,Brownlee M, Schleicher ED. 1999. Differential accumulation of advanced glycation end products in the course of diabetic retinopathy. Diabetologia 42: 728-736.   DOI
33 Bucala R, Vlassara H. 1995. Advanced glycosylation end products in diabetic renal and vascular disease. Am J Kidney Dis 26: 875-888.   DOI